| |
| |
|
| Insider
Information: |
Rhodes Jason P |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
138,000 |
|
|
Indirect Shares
|
23,308,240 |
|
|
| Direct
Value |
$202,860 |
|
|
|
Indirect Value
|
$404,071,929 |
|
|
| Total
Shares |
23,446,240 |
|
|
| Total
Value |
$404,274,789 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -2.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Epizyme, Inc. |
EPZM |
President, CFO and Tre... |
2014-09-22 |
138,000 |
2014-01-06 |
0 |
Premium* |
|
|
Replimune Group Inc |
REPL |
Director |
2018-07-24 |
0 |
2021-01-26 |
3,228,912 |
Premium* |
|
|
Generation Bio Co. |
GBIO |
Director |
|
0 |
2021-09-29 |
8,279,484 |
Premium* |
|
|
Dyne Therapeutics, Inc. |
DYN |
|
|
0 |
2024-03-01 |
6,545,479 |
Premium* |
|
|
Disc Medicine, Inc |
IRON |
Director |
|
0 |
2021-02-05 |
5,254,365 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REPL |
Replimune Group Inc |
Director |
– • – |
2021-01-26 |
4 |
AS |
$46.14 |
$256,446 |
I/I |
(5,558) |
946,000 |
0 |
% |
|
| REPL |
Replimune Group Inc |
Director |
– • – |
2020-12-08 |
4 |
AS |
$46.02 |
$5,056,591 |
I/I |
(108,256) |
32,234 |
0 |
% |
|
| REPL |
Replimune Group Inc |
Director |
– • – |
2020-12-07 |
4 |
AS |
$45.45 |
$3,120,459 |
I/I |
(67,890) |
35,709 |
0 |
% |
|
| REPL |
Replimune Group Inc |
Director |
– • – |
2020-12-11 |
4 |
AS |
$43.32 |
$1,372,512 |
I/I |
(31,636) |
25,757 |
0 |
% |
|
| REPL |
Replimune Group Inc |
Director |
– • – |
2020-12-14 |
4 |
AS |
$42.69 |
$1,637,847 |
I/I |
(37,659) |
23,481 |
0 |
% |
|
| REPL |
Replimune Group Inc |
Director |
– • – |
2020-12-10 |
4 |
AS |
$42.68 |
$1,484,083 |
I/I |
(34,391) |
27,669 |
0 |
% |
|
| REPL |
Replimune Group Inc |
Director |
– • – |
2020-12-09 |
4 |
AS |
$42.51 |
$1,804,182 |
I/I |
(41,216) |
29,748 |
0 |
% |
|
| REPL |
Replimune Group Inc |
Director |
– • – |
2020-12-15 |
4 |
AS |
$42.40 |
$1,731,253 |
I/I |
(40,819) |
21,013 |
0 |
% |
|
| REPL |
Replimune Group Inc |
Director |
– • – |
2020-12-16 |
4 |
AS |
$42.13 |
$533,998 |
I/I |
(12,675) |
20,247 |
0 |
% |
|
| REPL |
Replimune Group Inc |
Director |
– • – |
2020-12-17 |
4 |
AS |
$42.00 |
$484,470 |
I/I |
(11,535) |
19,550 |
0 |
% |
|
| REPL |
Replimune Group Inc |
Director |
– • – |
2020-12-18 |
4 |
AS |
$41.95 |
$181,182 |
I/I |
(4,319) |
19,285 |
0 |
% |
|
| EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
• – – |
2014-09-02 |
4 |
AS |
$33.37 |
$1,004,163 |
D/D |
(30,000) |
94,000 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
• – – |
2014-07-07 |
4 |
AS |
$32.52 |
$982,161 |
D/D |
(30,000) |
70,000 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
|
– • – |
2024-03-01 |
4 |
AS |
$30.05 |
$1,398,347 |
I/I |
(46,534) |
847,388 |
0 |
% |
|
| EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
• – – |
2014-08-04 |
4 |
AS |
$29.26 |
$892,324 |
D/D |
(30,000) |
82,000 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
President, CFO and Treasurer |
• – – |
2014-02-10 |
4 |
S |
$29.25 |
$1,462,500 |
D/D |
(50,000) |
24,000 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
Director |
– • – |
2021-04-07 |
4 |
AS |
$28.48 |
$1,136,671 |
I/I |
(39,864) |
227,913 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
Director |
– • – |
2021-04-08 |
4 |
AS |
$28.47 |
$1,241,241 |
I/I |
(43,550) |
184,363 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
Director |
– • – |
2021-04-09 |
4 |
AS |
$27.57 |
$1,205,948 |
I/I |
(43,681) |
140,682 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
Director |
– • – |
2021-04-14 |
4 |
AS |
$26.40 |
$622,995 |
I/I |
(23,413) |
0 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
Director |
– • – |
2021-09-23 |
4 |
AS |
$26.13 |
$1,972,127 |
I/I |
(75,465) |
811 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
Director |
– • – |
2021-04-12 |
4 |
AS |
$26.07 |
$1,938,229 |
I/I |
(74,124) |
66,558 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
Director |
– • – |
2021-09-22 |
4 |
AS |
$25.89 |
$792,705 |
I/I |
(30,617) |
951 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
Director |
– • – |
2021-09-24 |
4 |
AS |
$25.84 |
$747,161 |
I/I |
(28,916) |
757 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
Director |
– • – |
2021-06-24 |
4 |
AS |
$25.77 |
$801,618 |
I/I |
(31,008) |
608 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
